{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:39:07Z","timestamp":1779111547653,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01142-9","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:27:54Z","timestamp":1762529274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In-hospital mortality prognostication for cancer patients with febrile neutropenia"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9179-1016","authenticated-orcid":false,"given":"Amna","family":"Tahir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4309-3353","authenticated-orcid":false,"given":"Asim","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Ashfaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maleeha","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqra","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Zafar","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Ahad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junaid","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umair","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Aleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Masood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsun Waqar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3758-6581","authenticated-orcid":false,"given":"Safee Ullah","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1142_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210019","volume":"13","author":"H Moon","year":"2018","unstructured":"Moon, H., Choi, Y. J. & Sim, S. H. Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?. PLoS One 13, e0210019 (2018).","journal-title":"PLoS One"},{"key":"1142_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1200\/JCO.2014.57.2347","volume":"33","author":"A Carmona-Bayonas","year":"2015","unstructured":"Carmona-Bayonas, A. et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: Validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study. J. Clin. Oncol. 33, 465\u2013471 (2015).","journal-title":"J. Clin. Oncol."},{"key":"1142_CR3","doi-asserted-by":"publisher","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","volume":"21","author":"J de Naurois","year":"2010","unstructured":"de Naurois, J. et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann. Oncol. 21, v252\u2013v256 (2010).","journal-title":"Ann. Oncol."},{"key":"1142_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1200\/JCO.2007.13.8222","volume":"26","author":"LS Elting","year":"2008","unstructured":"Elting, L. S. et al. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J. Clin. Oncol. 26, 606\u2013611 (2008).","journal-title":"J. Clin. Oncol."},{"key":"1142_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski, D. F. et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit. Care Med. 38, 1045\u20131053 (2010).","journal-title":"Crit. Care Med."},{"key":"1142_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"RP Dellinger","year":"2008","unstructured":"Dellinger, R. P. et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36, 296\u2013327 (2008).","journal-title":"Crit. Care Med."},{"key":"1142_CR7","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","volume":"24","author":"TJ Smith","year":"2006","unstructured":"Smith, T. J. et al. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J. Clin. Oncol. 24, 3187\u20133205 (2006).","journal-title":"J. Clin. Oncol."},{"key":"1142_CR8","doi-asserted-by":"crossref","unstructured":"Herbst, C. et al. Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. Cochrane Database of Systematic Reviews (2009) doi:10.1002\/14651858.CD007107.PUB2\/MEDIA\/CDSR\/CD007107\/REL0002\/CD007107\/IMAGE_T\/TCD007107-AFIG-FIG01.PNG.","DOI":"10.1002\/14651858.CD007107.pub2"},{"key":"1142_CR9","doi-asserted-by":"crossref","unstructured":"Shmuely, H., Monely, L. & Shvidel, L. All-cause mortality and its predictors in haemato-oncology patients with febrile neutropenia. J. Clin. Med. 12, (2023).","DOI":"10.3390\/jcm12175635"},{"key":"1142_CR10","first-page":"3038","volume":"18","author":"J Klastersky","year":"2016","unstructured":"Klastersky, J. et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. Multicent. Study 18, 3038\u20133051 (2016).","journal-title":"Multicent. Study"},{"key":"1142_CR11","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer, N. M., Dale, D. C., Crawford, J., Cosler, L. E. & Lyman, G. H. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106, 2258\u20132266 (2006).","journal-title":"Cancer"},{"key":"1142_CR12","doi-asserted-by":"crossref","unstructured":"Nordvig, J. et al. Febrile neutropenia and long-term risk of infection among patients treated with chemotherapy for malignant diseases. Open Forum Infect Dis 5, (2018).","DOI":"10.1093\/ofid\/ofy255"},{"key":"1142_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2017.11.005","volume":"120","author":"Y Lalami","year":"2017","unstructured":"Lalami, Y. & Klastersky, J. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently emerging clinical data. Crit. Rev. Oncol. Hematol. 120, 163\u2013179 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1142_CR14","doi-asserted-by":"crossref","unstructured":"Du, X. et al. Predicting in-hospital mortality of patients with febrile neutropenia using machine learning models. Int. J. Med. Inform. 139, (2020).","DOI":"10.1016\/j.ijmedinf.2020.104140"},{"key":"1142_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/annonc\/mdg019","volume":"14","author":"MD Green","year":"2003","unstructured":"Green, M. D. et al. A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann. Oncol. 14, 29\u201335 (2003).","journal-title":"Ann. Oncol."},{"key":"1142_CR16","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/cncr.11827","volume":"98","author":"GH Lyman","year":"2003","unstructured":"Lyman, G. H. & Delgado, D. J. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma. Cancer 98, 2402\u20132409 (2003).","journal-title":"Cancer"},{"key":"1142_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.6004\/jnccn.2008.0012","volume":"6","author":"J Crawford","year":"2008","unstructured":"Crawford, J. et al. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J. Natl. Compr. Canc Netw. 6, 109\u2013118 (2008).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"1142_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","volume":"90","author":"GH Lyman","year":"2014","unstructured":"Lyman, G. H., Abella, E. & Pettengell, R. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review. Crit. Rev. Oncol. Hematol. 90, 190\u2013199 (2014).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1142_CR19","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1002\/cam4.2955","volume":"9","author":"T Aagaard","year":"2020","unstructured":"Aagaard, T. et al. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer. Cancer Med. 9, 3033 (2020).","journal-title":"Cancer Med."},{"key":"1142_CR20","unstructured":"2018 Requirements (2018 Common Rule) | HHS.gov. https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/regulations\/45-cfr-46\/revised-common-rule-regulatory-text\/index.html#46.116."},{"key":"1142_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","volume":"195","author":"HM Mehta","year":"2015","unstructured":"Mehta, H. M., Malandra, M. & Corey, S. J. G-CSF and GM-CSF in neutropenia. J. Immunol. 195, 1341\u20131349 (2015).","journal-title":"J. Immunol."},{"key":"1142_CR22","doi-asserted-by":"publisher","unstructured":"Giri, R. K. & Sahoo, R. K. Febrile neutropenia. Onco-critical Care: An Evidence-based Approach 233\u2013250 https:\/\/doi.org\/10.1007\/978-981-16-9929-0_21. (2023).","DOI":"10.1007\/978-981-16-9929-0_21"},{"key":"1142_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"E Erdfelder","year":"2009","unstructured":"Erdfelder, E., FAul, F., Buchner, A. & Lang, A. G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav. Res Methods 41, 1149\u20131160 (2009).","journal-title":"Behav. Res Methods"},{"key":"1142_CR24","doi-asserted-by":"publisher","first-page":"S574","DOI":"10.21037\/jtd.2019.01.25","volume":"11","author":"ME Shipe","year":"2019","unstructured":"Shipe, M. E., Deppen, S. A., Farjah, F. & Grogan, E. L. Developing prediction models for clinical use using logistic regression: an overview. J. Thorac. Dis. 11, S574\u2013S584 (2019).","journal-title":"J. Thorac. Dis."},{"key":"1142_CR25","doi-asserted-by":"crossref","unstructured":"Zhang, Z. & Kattan, M. W. Drawing nomograms with R: applications to categorical outcome and survival data. Ann. Transl. Med. 5, 211 (2017).","DOI":"10.21037\/atm.2017.04.01"},{"key":"1142_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3462-1","author":"FE Harrell","year":"2001","unstructured":"Harrell, F. E. Regres. Modeling Strateg. https:\/\/doi.org\/10.1007\/978-1-4757-3462-1 (2001).","journal-title":"Regres. Modeling Strateg."},{"key":"1142_CR27","doi-asserted-by":"crossref","unstructured":"Towards trustable machine learning. Nat. Biomed. Eng. 2, 709\u2013710 (2018).","DOI":"10.1038\/s41551-018-0315-x"},{"key":"1142_CR28","doi-asserted-by":"crossref","unstructured":"Okunaka, M., Kano, D., Matsui, R., Kawasaki, T. & Uesawa, Y. Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia. Pharmaceuticals 14 (2021).","DOI":"10.3390\/ph14070681"},{"key":"1142_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cmi.2015.01.029","volume":"21","author":"M Mar\u00edn","year":"2015","unstructured":"Mar\u00edn, M. et al. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection. Clin. Microbiol. Infect. 21, 583\u2013590 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"1142_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/10245330701384237","volume":"12","author":"J Ramzi","year":"2007","unstructured":"Ramzi, J. et al. Predictive factors of septic shock and mortality in neutropenic patients. Hematology 12, 543\u2013548 (2007).","journal-title":"Hematology"},{"key":"1142_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7861\/clinmedicine.13-2-185","volume":"13","author":"RT Clarke","year":"2013","unstructured":"Clarke, R. T., Jenyon, T., Parsons, V. V. H. & King, A. J. Neutropenic sepsis: management and complications. Clin. Med. 13, 185 (2013).","journal-title":"Clin. Med."},{"key":"1142_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1001\/archinte.158.8.868","volume":"158","author":"J Carratal\u00e0","year":"1998","unstructured":"Carratal\u00e0, J., Ros\u00f3n, B., Fern\u00e1ndez-Sevilla, A., Alcaide, F. & Gudiol, F. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch. Intern Med 158, 868\u2013872 (1998).","journal-title":"Arch. Intern Med"},{"key":"1142_CR33","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.2147\/IJGM.S447354","volume":"16","author":"C Zhao","year":"2023","unstructured":"Zhao, C. et al. Risk factors for 30-day mortality in patients with bacteremic pneumonia caused by escherichia coli and klebsiella pneumoniae: a retrospective Study. Int J. Gen. Med 16, 6163 (2023).","journal-title":"Int J. Gen. Med"},{"key":"1142_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s100960000410","volume":"19","author":"G Maschmeyer","year":"2000","unstructured":"Maschmeyer, G. & Braveny, I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur. J. Clin. Microbiol Infect. Dis. 19, 915\u2013925 (2000).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"1142_CR35","first-page":"259","volume":"55","author":"HY Chang","year":"1976","unstructured":"Chang, H. Y. et al. Causes of death in adults with acute leukemia. Med. (U. S.) 55, 259\u2013268 (1976).","journal-title":"Med. (U. S.)"},{"key":"1142_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MCP.0000000000000156","volume":"21","author":"SE Evans","year":"2015","unstructured":"Evans, S. E. & Ost, D. E. Pneumonia in the neutropenic cancer patient. Curr. Opin. Pulm. Med 21, 260 (2015).","journal-title":"Curr. Opin. Pulm. Med"},{"key":"1142_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2052-0492-1-9","volume":"1","author":"C Venkata","year":"2013","unstructured":"Venkata, C., Kashyap, R., Christopher Farmer, J. & Afessa, B. Thrombocytopenia in adult patients with sepsis: Incidence, risk factors, and its association with clinical outcome. J. Intensive Care 1, 1\u201310 (2013).","journal-title":"J. Intensive Care"},{"key":"1142_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.thromres.2016.02.022","volume":"141","author":"CM Larkin","year":"2016","unstructured":"Larkin, C. M., Santos-Martinez, M. J., Ryan, T. & Radomski, M. W. Sepsis-associated thrombocytopenia. Thromb. Res 141, 11\u201316 (2016).","journal-title":"Thromb. Res"},{"key":"1142_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08452-w","volume":"21","author":"WB Awad","year":"2021","unstructured":"Awad, W. B., Nazer, L., Elfarr, S., Abdullah, M. & Hawari, F. A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock. BMC Cancer 21, 1\u20137 (2021).","journal-title":"BMC Cancer"},{"key":"1142_CR40","doi-asserted-by":"crossref","unstructured":"Wu, Y. H., Chen, H. Y., Hong, W. C., Wei, C. Y. & Pang, J. H. S. Carboplatin-Induced thrombocytopenia through JAK2 downregulation, S-phase cell cycle arrest and apoptosis in megakaryocytes. Int. J. Mol. Sci. 23, 6290 (2022).","DOI":"10.3390\/ijms23116290"},{"key":"1142_CR41","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2165\/11594310-000000000-00000","volume":"34","author":"MJ Ten Berg","year":"2011","unstructured":"Ten Berg, M. J. et al. Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: Results from a retrospective hospital-based cohort study. Drug Saf. 34, 1151\u20131160 (2011).","journal-title":"Drug Saf."},{"key":"1142_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","volume":"2018","author":"T Bakchoul","year":"2018","unstructured":"Bakchoul, T. & Marini, I. Drug-associated thrombocytopenia. Hematology 2018, 576\u2013583 (2018).","journal-title":"Hematology"},{"key":"1142_CR43","doi-asserted-by":"crossref","unstructured":"Villafuerte-Gutierrez, P., Villalon, L., Losa, J. E. & Henriquez-Camacho, C. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update. Adv. Hematol. 2014, 986938 (2014).","DOI":"10.1155\/2014\/986938"},{"key":"1142_CR44","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/504490","volume":"43","author":"MA Pfaller","year":"2006","unstructured":"Pfaller, M. A., Pappas, P. G. & Wingard, J. R. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis. 43, S3\u2013S14 (2006).","journal-title":"Clin. Infect. Dis."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01142-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:28:08Z","timestamp":1762529288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01142-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01142-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4730716\/v1","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}